<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2024-4-50-55</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-3678</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Эффект Sedimentum Lateritium ХVI века раскрывает роль ренальных дисфункций в коморбидности болезней ХХI века</article-title><trans-title-group xml:lang="en"><trans-title>The effect of Sedimentum Lateritium of the 16th century reveals the role of renal dysfunction in the comorbidity of diseases of the 21st century</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6663-7045</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яковлева</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Iakovleva</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Яковлева Анастасия Владимировна, зав. лабораторией, врач клинической лабораторной диагностики</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Iakovleva Anastasiia V., head of laboratory, clinical laboratory diagnostics physician</p><p>St. Petersburg</p></bio><email xlink:type="simple">gi_ns@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4656-1025</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Момыналиев</surname><given-names>К. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Momynaliev</surname><given-names>K. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Момыналиев Куват Темиргалиевич, д. б. н., доцент, помощник генерального директора</p><p>Москва</p></bio><bio xml:lang="en"><p>Momynaliev Kuvat T., Dr Bio Sci, associate professor, assistant general director</p><p>Moscow</p></bio><email xlink:type="simple">dhoroshun@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Залеский</surname><given-names>М. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Zalesky</surname><given-names>M. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Залеский Михаил Григорьевич, к. б. н.</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Zaleskiу Mikhail G., PhD Bio Sci</p><p>St. Petersburg</p></bio><email xlink:type="simple">zalab@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3756-0701</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Верлов</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Verlov</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Верлов Николай Александрович, к. б. н., заведующий ресурсным центром Отделения молекулярной и радиационной биофизики</p><p>Ленинградская область, Гатчина</p></bio><bio xml:lang="en"><p>Verlov Nikolay A., PhD Bio Sci, head of Resource Center of Dept of Molecular and Radiation Biophysics</p><p>Leningrad region, Gatchina</p></bio><email xlink:type="simple">verlov_na@pnpi.nrcki.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2418-6471</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скибо</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Skibo</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Скибо Ирина Ивановна, врач клинической лабораторной диагностики высшей категории, ассистент кафедры клинической лабораторной диагностики с курсом молекулярной медицины</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Skibo Irina I., clinical laboratory diagnostics physician of the highest category, assistant of Dept of Clinical Laboratory Diagnostics with a Course in Molecular Medicine</p><p>St. Petersburg</p></bio><email xlink:type="simple">iskibo@invitro.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2079-0439</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Эмануэль</surname><given-names>В. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Emanuel</surname><given-names>V. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Эмануэль Владимир Леонидович, д. м. н., профессор, зав. кафедрой клинической лабораторной диагностики с курсом молекулярной медицины</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Emanuel Vladimir L., DM Sci (habil.), professor, head of Dept of Clinical Laboratory Diagnostics with a Course in Molecular Medicine</p><p>St. Petersburg</p></bio><email xlink:type="simple">vladimirem1@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pavlov First Saint Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Всероссийский научно-исследовательский и испытательный институт медицинской техники» Федеральной службы по надзору в сфере здравоохранения</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Scientific and Research Institute for Medical Engineering</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ «Петербургский институт ядерной физики имени Б. П. Константинова» Национального исследовательского центра «Курчатовский институт»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Petersburg Nuclear Physics Institute named by B. P. Konstantinov of National Research Centre “Kurchatov Institute”</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>09</day><month>05</month><year>2024</year></pub-date><volume>0</volume><issue>4</issue><issue-title>Современная лаборатория (1)</issue-title><fpage>50</fpage><lpage>55</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Яковлева А.В., Момыналиев К.Т., Залеский М.Г., Верлов Н.А., Скибо И.И., Эмануэль В.Л., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Яковлева А.В., Момыналиев К.Т., Залеский М.Г., Верлов Н.А., Скибо И.И., Эмануэль В.Л.</copyright-holder><copyright-holder xml:lang="en">Iakovleva A.V., Momynaliev K.T., Zalesky M.G., Verlov N.A., Skibo I.I., Emanuel V.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/3678">https://www.med-alphabet.com/jour/article/view/3678</self-uri><abstract><p>С целью изучения диагностической эффективности феномена Sedimentum lateritium, известного с XVI века, на основе сформированной лабораторной модели регистрации образования осадка в моче при ее охлаждении – холодовой пробы мочи (ХПМ), методами динамического светорассеивания и измерения Z-потенциала, верифицирован механизм образования «криогеля» в моче при полимеризации патологических изоформ уромодулина (UMD), характерных для больных уролитиазом.В результате анализа «непрофильной» когорты лиц кардиологического и пульмонологического профилей, описанный фазовый переход «золь-гель» выявлен с частотой 21–31 % соответственно. Выдвинута гипотеза о коморбидности, обусловленной метаболизмом различных изоформ UMD: при уролитиазе, в следствии нарушений апикального пострансляционного процессинга олиго-полимерных изоформ UMD и, в следствии воздействия ксенобиотиков и повреждений внутриклеточного метаболизма с деструкцией базальной мембраны и выходом мономерных изоформ UMD в интерстиций почек, инициирующего воспаление и, последующий фиброз с повышением внутрипочечного давления, снижающего СКФ, т. е. развитие ХБП.Вывод: описанная биофизическая технология может рассматриваться как скриниговый метод доклинической верификации каскада метаболических последствий по «кардио-гепато-ренальному» континууму, формирующему коморбидность заболеваний в популяции.</p></abstract><trans-abstract xml:lang="en"><p>For the purpose of studying the diagnostic effectiveness of the Sedimentum lateritium phenomenon, known since the XVI century, on the basis of a formed laboratory model for registering the formation of sediment in urine during cooling – a cold urine sample (CPM), by methods of dynamic light scattering and Z-potential measurement, the mechanism of formation of “cryogel” in urine during polymerization of pathological isoforms of uromodulin (UMD) was verified, characteristic of patients with urolithiasis. As a result of the analysis of a “non-core” cohort of individuals with cardiological and pulmonological profiles, the described sol-gel phase transition was detected with a frequency of 21–31 %, respectively. A hypothesis has been put forward about comorbidity due to the metabolism of various UMD isoforms: in urolithiasis, as a result of violations of apical posttranslational processing of oligo-polymer isoforms of UMD and, as a result of exposure to xenobiotics and damage to intracellular metabolism with destruction of the basement membrane and the release of monomeric isoforms of UMD into the interstitium of the kidneys, initiating inflammation and subsequent fibrosis with increased intrarenal pressure, reducing GFR, i. e. the development of CKD. Conclusion: the described biophysical technology can be considered as a screening method for preclinical verification of the cascade of metabolic consequences along the “cardio-hepatorenal” continuum that forms the comorbidity of diseases in the population.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эффект Sedimentum lateritium (Sl)</kwd><kwd>холодовая проба мочи (ХПМ)</kwd><kwd>уромодулин (UMD)</kwd><kwd>криогель</kwd><kwd>ренальные дисфункции</kwd><kwd>мочекаменная болезнь (МКБ)</kwd><kwd>коморбидные заболевания</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Sedimentum lateritium (Sl) effect</kwd><kwd>cold urine sample (CPM)</kwd><kwd>uromodulin (UMD)</kwd><kwd>cryogel</kwd><kwd>renal dysfunction</kwd><kwd>urolithiasis (ICD)</kwd><kwd>comorbid diseases</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">A. Tojo, S. Kinugasa Mechanisms of Glomerular Albumin Filtration and Tubular Reabsorption. International Journal of Nephrology. 2012;(2012): 9. http://doi.org/10.1155/2012/481520</mixed-citation><mixed-citation xml:lang="en">A. Tojo, S. Kinugasa Mechanisms of Glomerular Albumin Filtration and Tubular Reabsorption. International Journal of Nephrology. 2012;(2012): 9. http://doi.org/10.1155/2012/481520</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hajamohideen S. Raffi, James M. Bates Jr., Zoltan Laszik, Satish Kumar Tamm-Horsfall Protein Protects Against Urinary Tract Infection by Proteus Mirabilis.The Journal of Urology.2009;181(5):2332–2338</mixed-citation><mixed-citation xml:lang="en">Hajamohideen S. Raffi, James M. Bates Jr., Zoltan Laszik, Satish Kumar Tamm-Horsfall Protein Protects Against Urinary Tract Infection by Proteus Mirabilis.The Journal of Urology.2009;181(5):2332–2338</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">http://doi.org/10.1016/j.juro.2009.01.014</mixed-citation><mixed-citation xml:lang="en">http://doi.org/10.1016/j.juro.2009.01.014</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Serafini-Cessi F, Malagolini N, Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. American journal of kidney diseases.2003;42(4):658–676. http://doi.org/10.1016/S0272–6386(03)00829–1</mixed-citation><mixed-citation xml:lang="en">Serafini-Cessi F, Malagolini N, Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. American journal of kidney diseases.2003;42(4):658–676. http://doi.org/10.1016/S0272–6386(03)00829–1</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Brunati M, Perucca S, Han L, Cattaneo A, Consolato F, Andolfo A, Schaeffer C, Olinger E, Peng J, Santambrogio S, et al. The serine protease hepsin mediates urinary secretion and polymerisation of Zona Pellucida domain protein uromodulin. Elife. 2015; 4: e08887.https://doi.org/10.7554/eLife.08887</mixed-citation><mixed-citation xml:lang="en">Brunati M, Perucca S, Han L, Cattaneo A, Consolato F, Andolfo A, Schaeffer C, Olinger E, Peng J, Santambrogio S, et al. The serine protease hepsin mediates urinary secretion and polymerisation of Zona Pellucida domain protein uromodulin. Elife. 2015; 4: e08887.https://doi.org/10.7554/eLife.08887</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss GL, Stanisich JJ, Sauer MM, Lin CW, Eras J, Zyla DS, Trück J, Devuyst O, Aebi M, Pilhofer M, et al. Architecture and function of human uromodulin filaments in urinary tract infections.Science. 2020; 369:1005–1010. http://doi.org/10.1126/science.aaz9866</mixed-citation><mixed-citation xml:lang="en">Weiss GL, Stanisich JJ, Sauer MM, Lin CW, Eras J, Zyla DS, Trück J, Devuyst O, Aebi M, Pilhofer M, et al. Architecture and function of human uromodulin filaments in urinary tract infections.Science. 2020; 369:1005–1010. http://doi.org/10.1126/science.aaz9866</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kaice A. LaFavers, Radmila Micanovic, Angela R. Sabo, Lauren A. Maghak, Tarek M. El-Achkar.Evolving.Concepts in Uromodulin Biology, Physiology, and Its Role in Disease: a Tale of Two Forms. Hypertension. 2022;79:2409–2418. https://doi.org/10.1161/HYPERTENSIONAHA.122.18567</mixed-citation><mixed-citation xml:lang="en">Kaice A. LaFavers, Radmila Micanovic, Angela R. Sabo, Lauren A. Maghak, Tarek M. El-Achkar.Evolving.Concepts in Uromodulin Biology, Physiology, and Its Role in Disease: a Tale of Two Forms. Hypertension. 2022;79:2409–2418. https://doi.org/10.1161/HYPERTENSIONAHA.122.18567</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Верлов Н. А., Ланда С. Б., Егоров В. В., Эмануэль Ю. В., Эмануэль В. Л. Уромодулин: связь олигомерных форм и функции.Патологическая физиология и экспериментальная терапия. 2021;65(1):133–140 https://doi.org/10.25557/0031–2991.2021.01.133–140</mixed-citation><mixed-citation xml:lang="en">Verlov N. A., Landa S. B., Egorov V. V., Emanuel Yu.V., Emanuel V. L. Uromodulin: relationship between oligomeric forms and function. Pathological physiology and experimental therapy. 2021;65(1):133–140 https://doi.org/10.25557/0031–2991.2021.01.133–140</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Эмануэль В. Л., Ланда С. Б., Измайлов М. Исследование олигомерных форм белка Тамма-Хорсфалла у здоровых людей и больных мочекаменной болезнью методом динамического светорассеяния.Актуальные вопросы биологической химии и физики.2016;1(2):189–194.</mixed-citation><mixed-citation xml:lang="en">Emanuel V. L., Landa S. B., Izmailov M. Study of oligomeric forms of Tamm-Horsfall protein in healthy people and patients with urolithiasis using the dynamic light scattering method. Current issues of biological chemistry and physics. 2016; 1(2): 189–194.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Залеский М. Г. Способ формирования группы риска с заболеваниями почек. Пат.№ 2402769. Рос.Федерация. Заявл.27.04.09; Опубл. 27.10.10. Зарегистр. 27.10.2010. 9с.</mixed-citation><mixed-citation xml:lang="en">alesky M. G. Method for forming a risk group with kidney diseases. Pat. No. 2402769. Russian Federation. Application 04/27/09; Publ. 27.10.10. Register 10/27/2010. 9s.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Залеский М. Г. Эффект Sedimentum Lateritium является маркером патологических процессов в почках. Лаборатория ЛПУ.2018;13:43–46.</mixed-citation><mixed-citation xml:lang="en">Zalesky M. G. The effect of Sedimentum Lateritium is a marker of pathological processes in the kidneys. Laboratory LPU.2018;13:43–46.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Болотова Е., Являнская В., Дудникова А. Хроническая обструктивная болезнь легких как фактор развития дисфункции почек. Врач.2018;29(3):22–26 http://doi.org/10.29296/25877305–2018–03–05</mixed-citation><mixed-citation xml:lang="en">Bolotova E., Yavlyanskaya V., Dudnikova A. Chronic obstructive pulmonary disease as a factor in the development of kidney dysfunction. Doctor.2018;29(3):22–26 http://doi.org/10.29296/25877305–2018–03–05</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов А. В. Системный подход к анализу кардиоренальных взаимоотношений как первый шаг на пути к нефрологии формата П4.Нефрология.2011;15(2):11–19. http://doi.org/10.24884/1561–6274–2011–15–2–11–19</mixed-citation><mixed-citation xml:lang="en">Smirnov A. V. A systematic approach to the analysis of cardiorenal relationships as the first step towards nephrology in P4 format. Nephrology.2011;15(2):11–19. http://doi.org/10.24884/1561–6274–2011–15–2–11–19</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Залеский М. Г. Холодовая проба мочи – новый маркер патологических процессов в почках. Клиническая лабораторная диагностика.2015;9: 99–100.</mixed-citation><mixed-citation xml:lang="en">Zalesky M. G. Cold urine test is a new marker of pathological processes in the kidneys. Clinical laboratory diagnostics.2015;9: 99–100.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
